149 related articles for article (PubMed ID: 35490415)
21. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
Muzurović E; Mikhailidis DP; Mantzoros C
Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
[TBL] [Abstract][Full Text] [Related]
22. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
[TBL] [Abstract][Full Text] [Related]
23. Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes.
Krishan S
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S77-81. PubMed ID: 26810159
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
Qureshi K; Abrams GA
Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
[TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study - sample of São José do Rio Preto.
Andrade GC; Fujise LH; Santana JE; Oliveira F; Silva Rde C
Rev Assoc Med Bras (1992); 2016; 62(3):218-26. PubMed ID: 27310544
[TBL] [Abstract][Full Text] [Related]
26. Are statins 'IDEAL' for non-alcoholic fatty liver disease?
Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2014 Feb; 30(2):229-31. PubMed ID: 24127654
[TBL] [Abstract][Full Text] [Related]
27. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
[TBL] [Abstract][Full Text] [Related]
28. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
Yi M; Chen RP; Yang R; Chen H
Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
[TBL] [Abstract][Full Text] [Related]
29. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
[TBL] [Abstract][Full Text] [Related]
30. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
[TBL] [Abstract][Full Text] [Related]
31. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
[TBL] [Abstract][Full Text] [Related]
32. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
33. The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study.
Hamid O; Eltelbany A; Mohammed A; Alsabbagh Alchirazi K; Trakroo S; Asaad I
Ann Hepatol; 2022; 27(5):100727. PubMed ID: 35700934
[TBL] [Abstract][Full Text] [Related]
34. Non-alcoholic steatohepatitis is independently associated with a history of gestational diabetes mellitus.
Boustany A; Onwuzo S; Zeid HKA; Almomani A; Kumar P; Hitawala A; Asaad I
J Gastroenterol Hepatol; 2023 Jun; 38(6):984-988. PubMed ID: 36869600
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
[TBL] [Abstract][Full Text] [Related]
36. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
[TBL] [Abstract][Full Text] [Related]
37. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
[TBL] [Abstract][Full Text] [Related]
38. Liver hemodynamic patterns in nonalcoholic steatosis: Doppler ultrasonography and histological evaluation.
Gonçalves Dos Reis Monteiro ML; Ferreira De Almeida E Borges V; Machado De Alcântara T; Borges De Araújo L; De Fátima Pinheiro C; Lemos Debs Diniz A
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):19-29. PubMed ID: 26887796
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan.
Shah AS; Khan S; Rahim H; Chishti KA; Khan AG
Pak J Pharm Sci; 2018 Jan; 31(1):193-198. PubMed ID: 29348103
[TBL] [Abstract][Full Text] [Related]
40. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population.
Rabelo F; Stefano JT; Cavaleiro AM; Lima RVC; de Campos Mazo DF; Carrilho FJ; Correa-Giannella ML; Oliveira CP
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):330-335. PubMed ID: 30087027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
